Stock Events

Stock Events

Search...

Alnylam Pharmaceuticals (DUL.F) Q3 2024 Earnings

1AugConfirmed

Q4 2023

Q1 2024

Q2 2024

Q3 2024

-1.24

-0.28

0.68

1.64

Details

Expected EPS

-0.9888589314999999

Actual EPS

-0.1204775

Surprise EPS

0.87

Surprise Percent

+87.82%

Description

Alnylam Pharmaceuticals (DUL.F) has reported earnings of -0.1204775 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.